US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Monkeypox Concept

1,550.43

-1.1544-0.07%

Number of Gainers:6

Number of Losers:5

Number of Flat:1

PE:- -

High:1,562.48

Open:1,551.79

Low:1,540.01

Close:1,551.80

Loading ...

Jazz Pharmaceuticals to buy Chimerix for $935 million

Jazz Pharmaceuticals to Buy Chimerix for Roughly $935 Million

MT Newswires Live

Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio

THOMSON REUTERS

Chimerix Inc - Jazz to Fund Transaction Through Existing Cash and Investments

THOMSON REUTERS

Chimerix Inc - Deal Valued at $935 Million, or $8.55 per Share

THOMSON REUTERS

Chimerix Inc - Transaction Valued at $8.55 per Share

THOMSON REUTERS

Chimerix Inc - Transaction Valued at $935 Million, or $8.55 per Share

THOMSON REUTERS

Tonix Pharmaceuticals to Present at the 2025 Virtual Investor Summit

Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio

Bank of America Securities Remains a Buy on Gilead Sciences (GILD)

Chimerix Shares Halted for News Pending Premarket

THOMSON REUTERS

Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers

Wall Street Wary as Viatris (VTRS) Dives into Generic Weight Loss Drug Market

Siga Technologies Inc. (SIGA) Ascends While Market Falls: Some Facts to Note

Pharmaceutical Stocks Hit New Highs Amid Market Volatility

Emergent BioSolutions falls -16.0%

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4583/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4583"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4583\",,,,,undefined,":{"symbol":"BK4583","market":"US","secType":"PLATE","nameCN":"Monkeypox Concept","latestPrice":1550.6465,"timestamp":1741291483895,"preClose":1551.8009,"halted":0,"volume":40840607,"delay":0,"changeRate":-0.000744,"change":-1.154419,"pbRate":3.824438,"amount":959722630.481256,"amplitude":0.014477,"prevYearClose":1284.7982,"fiveDayClose":1511.4258,"twentyDayClose":1385.6759,"turnoverRate":0.014549,"marketCap":175653591794.5,"floatMarketCap":174865619947.5,"peRate":756.174276},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4583\",,,,,undefined,":{"symbol":"BK4583","high":1562.48,"amplitude":0.014477,"preClose":1551.8009,"low":1540.0138,"pbRate":"3.824438","latestPrice":1550.4265,"volume":40839693,"delay":0,"open":1551.7856,"prevYearClose":1284.7982,"prevWeekClose":1535.672,"prevMonthClose":1535.672,"prevQuarterClose":1284.7982,"fiveDayClose":1511.4258,"twentyDayClose":1385.6759,"sixtyDayClose":1305.8654,"secType":"PLATE","market":"US","turnoverRate":0.014548,"peRate":756.174276,"marketCap":175640904587.5,"floatMarketCap":174852994923.5,"timestamp":1741291481156,"nameCN":"Monkeypox Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4583\",,,,undefined,":{"bkCode":"BK4583","up":6,"down":5,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4583\",pageSize:16,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517913203","title":"Jazz Pharmaceuticals to buy Chimerix for $935 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2517913203","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517913203?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:06","pubTimestamp":1741176395,"startTime":"0","endTime":"0","summary":"Jazz Pharmaceuticals to buy Chimerix for $935 million March 5  - Jazz Pharmaceuticals JAZZ.O will acquire biotech firm Chimerix CMRX.O for about $935 million to gain access to its experimental drug to treat a rare brain tumor, the companies said on Wednesday.  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nL3N3PO12W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","BK4532","IE00BN0W2V16.EUR","JAZZ","LU0109394709.USD","IE00BN0W2T93.GBP","BK4533","BK4007","IE00BN0W2W23.USD","LU0320765992.SGD","BK4139","CMRX","LU0823416689.USD","BK4583"],"gpt_icon":0},{"id":"2517132009","title":"Jazz Pharmaceuticals to Buy Chimerix for Roughly $935 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2517132009","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517132009?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:05","pubTimestamp":1741176350,"startTime":"0","endTime":"0","summary":"Jazz Pharmaceuticals to Buy Chimerix for Roughly $935 Million","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","CMRX","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","BK4007","IE00BN0W2W23.USD","LU0109394709.USD","JAZZ","LU0823416689.USD","LU0889565916.HKD","LU0320765992.SGD","BK4583","BK4139","BK4533"],"gpt_icon":0},{"id":"2517913647","title":"Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2517913647","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517913647?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:00","pubTimestamp":1741176028,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nTUAS6S8X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMRX","LU0109394709.USD","BK4533","BK4583","BK4139","LU0320765992.SGD","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","JAZZ","LU0823416689.USD","IE00BN0W2V16.EUR","LU0889565916.HKD","BK4007","BK4532"],"gpt_icon":0},{"id":"2517939913","title":"Chimerix Inc - Jazz to Fund Transaction Through Existing Cash and Investments","url":"https://stock-news.laohu8.com/highlight/detail?id=2517939913","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517939913?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:00","pubTimestamp":1741176011,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nTUABDGJLF:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMRX","LU0109394709.USD","BK4533","BK4583","BK4139","LU0320765992.SGD","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","JAZZ","LU0823416689.USD","IE00BN0W2V16.EUR","LU0889565916.HKD","BK4007","BK4532"],"gpt_icon":0},{"id":"2517913622","title":"Chimerix Inc - Deal Valued at $935 Million, or $8.55 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2517913622","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517913622?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:00","pubTimestamp":1741176011,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nTUABDGJLF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4583","BK4007","LU0109394709.USD","LU0889565916.HKD","LU0823416689.USD","LU0320765992.SGD","BK4139","IE00BN0W2W23.USD","CMRX","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","JAZZ","BK4533","BK4532"],"gpt_icon":0},{"id":"2517913678","title":"Chimerix Inc - Transaction Valued at $8.55 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2517913678","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517913678?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:00","pubTimestamp":1741176002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nTUA2NCTXB:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","IE00BN0W2V16.EUR","BK4533","BK4139","LU0109394709.USD","JAZZ","CMRX","IE00BN0W2T93.GBP","BK4583","LU0823416689.USD","BK4532","LU0889565916.HKD","IE00BN0W2W23.USD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2517648913","title":"Chimerix Inc - Transaction Valued at $935 Million, or $8.55 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2517648913","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517648913?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:00","pubTimestamp":1741176002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nTUA2NCTXB:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0109394709.USD","BK4007","LU0320765992.SGD","BK4583","LU0889565916.HKD","LU0823416689.USD","CMRX","BK4532","BK4139","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","JAZZ","BK4533"],"gpt_icon":0},{"id":"2517913074","title":"Tonix Pharmaceuticals to Present at the 2025 Virtual Investor Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2517913074","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517913074?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:00","pubTimestamp":1741176000,"startTime":"0","endTime":"0","summary":"CHATHAM, N.J., March 05, 2025  -- Tonix Pharmaceuticals Holding Corp.  , a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, announced today that Jessica Morris, Chief Operating Officer of Tonix Pharmaceuticals, will present at the 2025 Virtual Investor Summit on Tuesday, March 11, 2025, at 10:30 a.m. ET.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tonix-pharmaceuticals-present-2025-virtual-120000539.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SMMF","BK4135","BK4583","BK4211","CNS","BK4139","TNXP"],"gpt_icon":1},{"id":"2517791378","title":"Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2517791378","media":"PR Newswire","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517791378?lang=en_us&edition=fundamental","pubTime":"2025-03-05 20:00","pubTimestamp":1741176000,"startTime":"0","endTime":"0","summary":"-Dordaviprone addresses a significant unmet patient need for patients with rare, high-grade brain tumors-. -Transaction to add near-term commercial opportunity to Jazz's pipeline-. -Transaction represents total cash consideration of approximately $935 million, or $8.55 per share-. DUBLIN and DURHAM, N.C., March 5, 2025 /PRNewswire/ --Jazz Pharmaceuticals plc   and Chimerix  , today announced the companies have entered into a definitive agreement for Jazz to acquire Chimerix for $8.55 per share in cash, representing a total consideration of approximately $935 million. The transaction has been approved by both companies and is expected to close in the second quarter of 2025.\"We are excited to reach this agreement with Jazz Pharmaceuticals as they bring global scale to broaden our dordaviprone commercial strategy,\" said Mike Andriole, President and CEO of Chimerix. \"The transaction, if approved, provides the opportunity to advance access to dordaviprone to reach more patients globally. Th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/jazz-pharmaceuticals-acquire-chimerix-further-120000916.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/jazz-pharmaceuticals-acquire-chimerix-further-120000916.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0889565916.HKD","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","LU0823416689.USD","JAZZ","BK4007","LU0320765992.SGD","IE00BN0W2T93.GBP","BK4532","LU0109394709.USD","BK4533","BK4139","BK4583","CMRX"],"gpt_icon":0},{"id":"2517991313","title":"Bank of America Securities Remains a Buy on Gilead Sciences (GILD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517991313","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517991313?lang=en_us&edition=fundamental","pubTime":"2025-03-05 19:57","pubTimestamp":1741175855,"startTime":"0","endTime":"0","summary":"In a report released today, Tim Anderson from Bank of America Securities maintained a Buy rating on Gilead Sciences (GILD – Research Report), with ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-remains-a-buy-on-gilead-sciences-gild?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-remains-a-buy-on-gilead-sciences-gild?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2089984988.USD","LU0170899867.USD","LU0130102774.USD","GILD","LU0130103400.USD","LU0971096721.USD","LU1496350171.SGD","LU0417517546.SGD","IE00BBT3K403.USD","LU0208291251.USD","BK4550","LU0256863902.USD","LU1280957306.USD","LU1668664300.SGD","LU0098860793.USD","LU0648000940.SGD","LU1880398554.USD","LU1571399168.USD","BK4578","BAC","LU1883839398.USD","LU2133065610.SGD","LU0053666078.USD","BK4207","LU0109394709.USD","LU0320765992.SGD","LU1066051498.USD","BK4532","BK4139","BK4585","LU2087621335.USD","LU0058720904.USD","BK4588","LU2129689605.HKD","LU1363072403.SGD","IE00BLSP4452.SGD","LU0256863811.USD","BK4568","LU1201861165.SGD","LU0289739699.SGD","BK4583","LU1894683264.USD","LU1880398471.USD","LU1162221912.USD","BK4504","LU1791807156.HKD","IE00BLSP4239.USD","IE00BKVL7J92.USD","LU2129689431.USD","LU1201861249.SGD"],"gpt_icon":0},{"id":"2517091382","title":"Chimerix Shares Halted for News Pending Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=2517091382","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517091382?lang=en_us&edition=fundamental","pubTime":"2025-03-05 19:57","pubTimestamp":1741175849,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nL3N3PO12P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4583","CMRX","BK4139"],"gpt_icon":0},{"id":"2517992400","title":"Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2517992400","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517992400?lang=en_us&edition=fundamental","pubTime":"2025-03-05 17:03","pubTimestamp":1741165429,"startTime":"0","endTime":"0","summary":"Wrapping up Q4 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including Amneal  and its peers.The 4 generic pharmaceuticals stocks we track reported a slower Q4. As a group, revenues beat analysts’ consensus estimates by 2.2%.While some generic pharmaceuticals stocks have fared somewhat better than others, they have collectively declined. On average, share prices are down 3.1% since the latest earnings results.Founded in 2002, Amneal Pharmaceuticals  develops, manufactures, and distributes a diverse portfolio of pharmaceuticals.ANI Pharmaceuticals reported revenues of $190.6 million, up 44.8% year on year, outperforming analysts’ expectations by 8.5%. The business had a stunning quarter with an impressive beat of analysts’ full-year EPS guidance estimates.ANI Pharmaceuticals achieved the biggest analyst estimates beat, fastest revenue growth, and highest full-year guidance raise among its peers. The market seems happy with the results as the ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/generic-pharmaceuticals-stocks-q4-review-090349719.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4112","BK4557","NQmain","AMRX","SQQQ","VTRS","ANIP","BK4585","NDAQ","LU2087621335.USD","QLD","IE00BGHQF748.EUR","AMPH","QID","LU2095319765.USD","MNQmain","TQQQ","BK4583","LU1839511570.USD","IE00B64PRP62.GBP","PSQ","IE00B3QW5Z07.USD","LU2210149790.SGD","USAW.SI","LU2210150020.SGD","USJW.SI",".IXIC","TSYW.SI","NVIW.SI","BK4007","BK4588","IE00BKPKM429.USD"],"gpt_icon":1},{"id":"2517939999","title":"Wall Street Wary as Viatris (VTRS) Dives into Generic Weight Loss Drug Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2517939999","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517939999?lang=en_us&edition=fundamental","pubTime":"2025-03-05 08:46","pubTimestamp":1741135560,"startTime":"0","endTime":"0","summary":"Viatris Inc. ($VTRS) recently reported a fourth quarter that fell short of Wall Street expectations, missing revenue and earnings targets. The comp...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/wall-street-wary-as-viatris-vtrs-dives-into-generic-weight-loss-drug-market?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/wall-street-wary-as-viatris-vtrs-dives-into-generic-weight-loss-drug-market?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2087621335.USD","BK4583","BK4007","BK4588","VTRS","BK4585","LU1839511570.USD"],"gpt_icon":0},{"id":"2517936581","title":"Siga Technologies Inc. (SIGA) Ascends While Market Falls: Some Facts to Note","url":"https://stock-news.laohu8.com/highlight/detail?id=2517936581","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517936581?lang=en_us&edition=fundamental","pubTime":"2025-03-05 06:45","pubTimestamp":1741128322,"startTime":"0","endTime":"0","summary":"Siga Technologies Inc.  closed the most recent trading day at $5.43, moving +0.74% from the previous trading session. The stock's performance was ahead of the S&P 500's daily loss of 1.22%. At the same time, the Dow lost 1.55%, and the tech-heavy Nasdaq lost 0.35%.The company's shares have seen a decrease of 6.75% over the last month, not keeping up with the Medical sector's gain of 0.98% and the S&P 500's loss of 2.31%.Investors will be eagerly watching for the performance of Siga Technologies Inc. in its upcoming earnings disclosure.Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Siga Technologies Inc. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.Investors should also note Siga Technologies Inc.'s current valuation metrics, including its Forward P/E ratio of 4.31. This expresses a discount compared to the av","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/siga-technologies-inc-siga-ascends-224522698.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","SIGA","BK4583"],"gpt_icon":0},{"id":"2517398310","title":"Pharmaceutical Stocks Hit New Highs Amid Market Volatility","url":"https://stock-news.laohu8.com/highlight/detail?id=2517398310","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517398310?lang=en_us&edition=fundamental","pubTime":"2025-03-05 01:34","pubTimestamp":1741109640,"startTime":"0","endTime":"0","summary":"The stock market has a way of proving the masses wrong.After all the chatter about the new administration’s potentially adverse impact on pharmaceutical stocks and related industries, the broader health care sector is leading the charge in 2025.Following the latest market volatility, the S&P 500 is now in negative territory on the year. It’s somewhat surprising to peak behind the curtain and see that 9 of 11 S&P sectors remain green.The price action in the stock market has been fast and furious as investors repositioned their portfolios for the new year. Sector rotation has been on full display, with institutions foregoing growth and technology positions and shifting to more defensive areas like staples, health care and utilities.Historical research studies suggest that approximately half of a stock’s price appreciation is due to its industry grouping. In fact, the top 50% of Zacks Ranked Industries","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pharmaceutical-stocks-hit-highs-amid-173400932.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1571399168.USD","BK4585","LU2468319806.SGD","LU0320765992.SGD","LU1430594728.SGD","BK4583","IE00B19Z3B42.SGD","LU0289739699.SGD","LU1066053197.SGD","LU0234570918.USD","BK4566","IE00BZ1G4Q59.USD","GILD","BK4568","IE00B19Z3581.USD","BK4550","LU0058720904.USD","BK4588","IE00B7SZLL34.SGD","BK4532","IE00BSNM7G36.USD","LU1585245621.USD","LU2089984988.USD","BK4578","IE0002270589.USD","LU1066051498.USD","LU2087621335.USD","LU0889565916.HKD","LU0109394709.USD","BK4139","LU1839511570.USD","IE00B3T34201.USD","IE00BKVL7J92.USD"],"gpt_icon":0},{"id":"2516083756","title":"Emergent BioSolutions falls -16.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516083756","media":"TIPRANKS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516083756?lang=en_us&edition=fundamental","pubTime":"2025-03-04 22:51","pubTimestamp":1741099911,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions (EBS) is down -16.0%, or -$1.09 to $5.74. Published first on TheFly – the ultimate source for real-time, market-moving breaki...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/emergent-biosolutions-falls-16-0?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/emergent-biosolutions-falls-16-0?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4583","EBS"],"gpt_icon":0}],"pageSize":16,"totalPage":8,"pageCount":3,"totalSize":126}]}}